The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of immune-related adverse events (irAE) on overall survival (OS) in patients treated with immunotherapy for non-small cell lung cancer (NSCLC).
 
Dwight Hall Owen
No Relationships to Disclose
 
Lai Wei
No Relationships to Disclose
 
Miguel Angel Villalona-Calero
Consulting or Advisory Role - Lilly
Research Funding - GlaxoSmithKline; Oncolytics
 
Erin Marie Bertino
Consulting or Advisory Role - Boehringer Ingelheim
 
Kai He
No Relationships to Disclose
 
Peter G. Shields
No Relationships to Disclose
 
David P. Carbone
Consulting or Advisory Role - Genentech
 
Gregory Alan Otterson
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Genentech/Roche (Inst)
Research Funding - Acerta Pharma (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Ignyta (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Xcovery (Inst)